REKLAMA

SOPHARMA AD: Notification from "Telso" AD under Art. 19 of Regulation (EU) No 596/2014 of 30 September 2022.

2022-10-03 14:12
publikacja
2022-10-03 14:12
Spis treści:

1. REPORT

2. INFORMATION ABOUT THE ENTITY

3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY


Spis załączników:
Current_report_insiders_transaction_Telso_81.pdf  (REPORT)

POLISH FINANCIAL SUPERVISION AUTHORITY
UNI - EN REPORT No 81 / 2022
Date of issue: 2022-10-03
Short name of the issuer
SOPHARMA AD
Subject
Notification from "Telso" AD under Art. 19 of Regulation (EU) No 596/2014 of 30 September 2022.
Official market - legal basis
art. 56. 1. 2 of Act on Public Offering.
Unofficial market - legal basis
Contents of the report:
Notification from "Telso" AD under Art. 19 of Regulation (EU) No 596/2014 of 30 September 2022.
Annexes
File Description
Current_report_insiders_transaction_Telso_81.pdfCurrent_report_insiders_transaction_Telso_81.pdf Notification from "Telso" AD under Art. 19 of Regulation (EU) No 596/2014 of 30 September 2022.

SOPHARMA AD
(fullname of the issuer)
SOPHARMA AD Farmaceutyczny (far)
(short name of the issuer) (sector according to clasification
of the WSE in Warsow)
1220 Sofia
(post code) (city)
IlienskoShosse 16
(street) (number)
+359 2 813 42 00 +359 2 936 02 86
(phone number) (fax)
(e-mail) (web site)
nd
(NIP) (REGON)

SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Date Name Position / Function Signature
2022-10-03 Ognian Donev Executive Director
Źródło:Komunikaty spółek (ESPI)
Tematy
Podróżuj bez limitu. Oszczędzaj czas i pieniądze.

Podróżuj bez limitu. Oszczędzaj czas i pieniądze.

Komentarze (0)

dodaj komentarz

Powiązane

Polecane

Najnowsze

Popularne

Ważne linki